Strategic Partnerships Zealand Pharma is seeking partnerships for the development and commercialization of their weight-loss drug petrelintide, presenting a sales opportunity for pharmaceutical companies looking to collaborate and access innovative peptide medicines.

Expanded Product Pipeline With over 10 drug candidates in clinical development and a focus on specialty gastrointestinal and metabolic diseases, Zealand Pharma offers a diverse range of potential products for businesses interested in expanding their portfolio or catering to these therapeutic areas.

Financial Health Having completed an upsized equity offering of $1 billion and planning for additional financing, Zealand Pharma's strong financial position presents a sales opportunity for financial institutions, investors, and service providers looking to engage with a well-funded biotechnology company.

Leadership Team Expansion The recent hiring of Eric Cox as Chief Commercial Officer indicates Zealand Pharma's focus on strengthening its commercial operations, offering a sales opportunity for professionals and vendors in the commercialization and marketing space seeking to partner with a growing biotech firm.

Employee Incentive Programs Zealand Pharma's launch of long-term incentive programs demonstrates a commitment to employee engagement and retention. This presents a sales opportunity for companies providing HR solutions or services aimed at fostering a motivated and rewarded workforce.